author-photo

Tao Wan

Chinese PLA General Hospital

5

Papers

21

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

PD-1 inhibitor combined with lenvatinib for unresectable liver cancer as the conversion therapy: An open-label, non-randomized, phase IV study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Two cases of intrahepatic cholangiocellular carcinoma with high insertion-deletion ratios that achieved a complete response following chemotherapy combined with PD-1 blockade

2019 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (20)
The successful transformation of IV stage intrahepatic cholangiocarcinoma by precision medicine: a case report

2019 Chinese Journal of Hepatobiliary Surgery
Show All
- Source
- Cite
- Save
Citations (0)
Are CYP1A1 polymorphisms associated with the risk of hepatocellular carcinoma

2013 Molecular Biology Reports
- Tao Wan
Show All
- Source
- Cite
- Save
Citations (0)